查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233128

放射肿瘤学市场规模、份额和趋势分析报告：按类型（外束放疗、内束放疗）、技术、应用、地区、细分趋势，2023-2030 年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

放射肿瘤学市场增长和趋势

Grand View Research, Inc. 的最新报告显示，2023 年至 2030 年全球放射肿瘤学市场的复合年增长率将达到 12.3%，到 2030 年将达到 211.4 亿，预计将达到美国美元。

市场增长受全球癌症负担不断增加、人口老龄化以及政府和私营组织实施的支持性报销计划等因素推动。 此外，放射治疗领域不断创新和进步为市场增长提供了机会。

世界正在见证癌症患者的增加，这是推动放射肿瘤学市场增长的主要因素。 例如，根据 Globocan 的数据，2020 年将有超过 2000 万人被诊断出患有癌症，1000 万人将死于癌症。 此外，由于免疫力下降和合併症，老龄化社会增加了患癌症的风险，从而增加了老年人口，进一步推动了市场增长。 例如，据世界卫生组织估计，2020年全球老年人口约为10亿，预计2050年将达到21亿。

为开发新型放射治疗技术和多学科治疗方法而开展的广泛研究活动有望​​提高癌症存活率和改善预后。 例如，2022 年 12 月，Elekta Unity 展示了 MR-Linac 在胰腺肿瘤中的应用，首例患者接受了新的先进放射治疗运动管理。

同样，2020 年 6 月，Isolei 与UC Physics就治疗颈部和头部癌症达成了一项研究协议。 两家公司计划在手术切除后评估 Keytruda 和铯 131 的疗效。 在癌症治疗中使用此类医用同位素有可能通过瞭解疾病的复杂性和患者需求来扩大市场机会，促进新型靶向特异性放射治疗系统的研究和开发。我有。

此外，放疗的支持性报销和监管政策也有望推动放疗市场的增长。 例如，2021 年 7 月，医疗保险和医疗补助服务中心 (CMS) 为癌症诊断和放射治疗服务开发了一种新的放射肿瘤学支付模式 (RO-APM)。 这可以提高患者护理质量并减少每年的医疗保险支出。

放射肿瘤学市场报告要点

  • 按类型划分，外照射放射治疗 (EBRT) 领域由于技术的快速进步而被引入以治疗各种类型的癌症，到 2022 年将占据放射肿瘤学市场 64.53% 的份额。
  • 就技术而言，由于治疗需求未得到满足的国家越来越多地使用技术先进的调强放疗 (IMRT)，调强放疗 (IMRT) 细分市场将在 2022 年占据市场主导地位。底部。 然而，近距离放射治疗估计是预测期内增长最快的部分。
  • 到 2022 年，EBRT 细分市场将在应用领域占据最高的市场份额。 此外，EBRT 部分预计将在预测期内保持其主导地位。
  • 北美在 2022 年占据了全球市场的主导地位，原因包括新癌症患者的增加、医疗保健专业人员对先进放射疗法的高度认识以及该地区医疗保健服务的改善等。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 细分范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法：产品流方法
  • 次要信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场概览

第 3 章市场变量、趋势和范围

  • 市场细分
  • 市场定义
  • 优先关键机会
  • 市场动态分析
    • 放疗的采用率提高
    • 放射治疗的技术进步
    • 癌症患病率上升
    • 不断上涨的医疗费用
    • 增加放射性药物的应用
  • 市场製约因素分析
    • 缺乏熟练的放射治疗专业人员
    • 辐射基础设施不足
    • 放疗的副作用
  • 商业环境分析
    • SWOT 分析；按因素（政治和法律、经济和技术）
    • 波特的五力分析

第 4 章放射肿瘤学市场 - 细分分析，按类型，2018-2030（百万美元）

  • 放射肿瘤学市场：类型变异分析
  • 外部放射治疗
    • 电子发射高能直线加速器
    • 紧凑型先进放射治疗系统
      • 网络刀
      • 伽玛刀
      • 断层扫瞄疗法
    • 质子治疗
      • 迴旋加速器
      • 同步加速器
  • 内部放疗
    • 近距离放射治疗
      • 种子
      • 涂抹器和后装器
      • 电子近距离放射治疗
    • 全身放疗
    • 其他

第 5 章放射肿瘤学市场 - 细分分析，按技术，2018-2030 年（百万美元）

  • 放射肿瘤学市场：技术波动分析
  • 外照射放射治疗 (EBRT)
    • 图像引导放射治疗 (IGRT)
    • 调强放射治疗 (IMRT)
    • 立体定向放射治疗
    • 质子治疗
    • 3D 适形放疗 (3D-CRT)
    • 容积调製电弧疗法 (VMAT)
  • 近距离放射治疗
    • 低剂量率 (LDR) 近距离放射治疗
    • 高剂量率 (HDR) 近距离放射治疗

第 6 章放射肿瘤学市场 - 细分分析，按应用，2018-2030 年（百万美元）

  • 放射肿瘤学市场：应用差异分析
  • 外照射放射治疗 (EBRT)
    • 前列腺癌
    • 乳腺癌
    • 肺癌
    • 头颈癌
    • 结肠癌
    • 其他
  • 内部放疗
    • 前列腺癌
    • 妇科癌症
    • 乳腺癌
    • 宫颈癌
    • 阴茎癌
    • 其他

第 7 章放射肿瘤学市场 - 细分分析，按地区，2018-2030 年（百万美元）

  • 定义和范围
  • 北美
    • 北美，SWOT 分析
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 欧洲
    • 欧洲，SWOT 分析
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 其他欧洲
  • 亚太地区
    • 亚太地区，SWOT 分析
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 亚太地区的其他国家/地区
  • 拉丁美洲
    • 拉丁美洲，SWOT 分析
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 其他拉丁语美国
  • 多边环境协定
    • 中东和非洲，SWOT 分析
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • MEA 的剩余部分

第八章竞争格局

  • 上市公司
    • 公司市场分析
    • 竞争仪表板分析
    • 战略框架
  • 私人公司
    • 主要初创企业/技术颠覆者/创新者名单
    • 本地网络地图
  • 公司简介
    • Varian Medical Systems, Inc.（A Part Of Siemens Healthineers）
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Elekta AB
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Accuray Incorporated
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Ion Beam Applications（IBA）.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • BD（Becton, Dickinson And Company）
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Isoray Medical
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Mevion Medical Systems
      • 公司概况
      • 产品基准
      • 战略举措
    • Nordion Inc.
      • 公司概况
      • 产品基准
      • 战略举措
    • NTP Radioisotopes SOC Ltd.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Curium
      • 公司概况
      • 产品基准
      • 战略举措
    • VIEWRAY TECHNOLOGIES, INC.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market is expected to reach USD 21.14 billion by 2030, registering a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • By type, the external beam radiation therapy (EBRT) segment accounted for a 64.53% share of the radiation oncology market in 2022 due to the rapid technological advancement, and increased adoption in the treatment of various types of cancers
  • Based on technology, in 2022 intensity-modulated radiotherapy (IMRT) segment dominated the market due to the increased availability of technologically advanced IMRT's in countries with unmet treatment needs. However, brachytherapy is estimated to be the fastest-growing segment during the forecast period
  • In 2022, EBRT segment held the highest market share in the application space. Moreover, EBRT segment is also anticipated to maintain its dominance during the forecast period
  • North America dominated the global market in 2022 owing to the factors such as the increase in new cancer cases, high awareness among healthcare professionals about advanced radiotherapy, and better healthcare access in the region

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline:
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Definitions
  • 3.3 Key Opportunities Prioritized
  • 3.4 Market Dynamic Analysis
    • 3.4.1 Rising Adoption Of Radiotherapy
    • 3.4.2 Technological Advancements In Radiotherapy
    • 3.4.3 Rising Prevalence Of Cancer
    • 3.4.4 Increase In Healthcare Expenditure
    • 3.4.5 Increasing APPLICATION OF Radiopharmaceuticals
  • 3.5 Market Restraint Analysis
    • 3.5.1 Lack Of Skilled Radiotherapy Professionals
    • 3.5.2 Inadequate Radiation Infrastructure
    • 3.5.3 Adverse Effects Of Radiotherapy
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By Factor (POLITICAL & LEGAL, Economic And Technological)
    • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Radiation Oncology Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Radiation Oncology Market: Type Movement Analysis
  • 4.2 External Beam Radiation Therapy
    • 4.2.1 External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.2.2 Electron-Emitting High Energy Linear Accelerators
      • 4.2.2.1 Electron-Emitting High Energy Linear Accelerators Market, 2018 - 2030 (USD Million)
    • 4.2.3 Compact Advanced Radiotherapy Systems
      • 4.2.3.1 Compact Advanced Radiotherapy Systems Market, 2018 - 2030 (USD Million)
      • 4.2.3.2 Cyberknife
      • 4.2.3.2.1 Cyberknife Market, 2018 - 2030 (USD Million)
      • 4.2.3.3 Gamma Knife
      • 4.2.3.3.1 Gamma Knife Market, 2018 - 2030 (USD Million)
      • 4.2.3.4 Tomotherapy
      • 4.2.3.4.1 Tomotherapy Compact Market, 2018 - 2030 (USD Million)
    • 4.2.4 Proton Therapy
      • 4.2.4.1 Proton Therapy Market, 2018 - 2030 (USD Million)
      • 4.2.4.2 Cyclotron
      • 4.2.4.2.1 Cyclotron Market, 2018 - 2030 (USD Million)
      • 4.2.4.3 Synchrotron
      • 4.2.4.3.1 Synchrotron Market, 2018 - 2030 (USD Million)
  • 4.3 Internal Beam Radiation Therapy
    • 4.3.1 Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.2 Brachytherapy
      • 4.3.2.1 Brachytherapy Market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Seeds
      • 4.3.2.2.1 Seeds Market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Applicators And After-Loaders
      • 4.3.2.3.1 Applicators And After-Loaders Market, 2018 - 2030 (USD Million)
      • 4.3.2.4 Electronic Brachytherapy
      • 4.3.2.4.1 Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
    • 4.3.3 Systemic Beam Radiation Therapy
      • 4.3.3.1 Systemic Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.4 Others
      • 4.3.4.1 Others Market, 2016-2028 (USD Million)

Chapter 5 Radiation Oncology Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Radiation Oncology Market: Technology Movement Analysis
  • 5.2 External Beam Radiation Therapy (EBRT)
    • 5.2.1 EBRT Market, 2018 - 2030 (USD Million)
    • 5.2.2 Image-Guided Radiation Therapy (IGRT)
      • 5.2.2.1 IGRT Market, 2018 - 2030 (USD Million)
    • 5.2.3 Intensity Modulated Radiotherapy (IMRT)
      • 5.2.3.1 IMRT Market, 2018 - 2030 (USD Million)
    • 5.2.4 Stereotactic Radiotherapy
      • 5.2.4.1 Stereotactic Radiotherapy Market, 2018 - 2030 (USD Million)
    • 5.2.5 Proton Beam Therapy
      • 5.2.5.1 Proton Beam Therapy Market, 2018 - 2030 (USD Million)
    • 5.2.6 3D Conformal Radiotherapy (3D-CRT)
      • 5.2.6.1 3D-CRT Market, 2018 - 2030 (USD Million)
    • 5.2.7 Volumetric Modulated Arc Therapy (VMAT)
      • 5.2.7.1 VMAT Market, 2018 - 2030 (USD Million)
  • 5.3 Brachytherapy
    • 5.3.1 Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.2 Low Dose Rate (LDR) Brachytherapy
      • 5.3.2.1 LDR Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.3 High Dose Rate (HDR) Brachytherapy
      • 5.3.3.1 HDR Brachytherapy Market, 2018 - 2030 (USD Million)

Chapter 6 Radiation Oncology Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Radiation Oncology Market: Application Movement Analysis
  • 6.2 External Beam Radiation Therapy (EBRT)
    • 6.2.1 Prostate Cancer
      • 6.2.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.2 Breast Cancer
      • 6.2.2.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.3 Lung Cancer
      • 6.2.3.1 Lung Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.4 Head And Neck Cancer
      • 6.2.4.1 Head And Neck Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.5 Colorectal Cancer
      • 6.2.5.1 Colorectal Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.6 Others
      • 6.2.6.1 Others Market, 2018 - 2030 (USD Million)
  • 6.3 Internal Beam Radiation Therapy
    • 6.3.1 Prostate Cancer
      • 6.3.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.2 Gynecologic Cancer
      • 6.3.2.1 Gynecologic Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.3 Breast Cancer
      • 6.3.3.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.4 Cervical Cancer
      • 6.3.4.1 Cervical Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.5 Penile Cancer
      • 6.3.5.1 Penile Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.6 Others
      • 6.3.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Radiation Oncology Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 North America
    • 7.2.1 North America, SWOT Analysis
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.2.2 Key Country Dynamics
      • 7.2.2.3 Target Disease Prevalence
      • 7.2.2.4 Competitive Scenario
      • 7.2.2.5 Regulatory Framework
      • 7.2.2.6 Reimbursement Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.3.2 Key Country Dynamics
      • 7.2.3.3 Target Disease Prevalence
      • 7.2.3.4 Competitive Scenario
      • 7.2.3.5 Regulatory Framework
      • 7.2.3.6 Reimbursement Scenario
  • 7.3 Europe
    • 7.3.1 Europe, SWOT Analysis
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 Key Country Dynamics
      • 7.3.2.3 Target Disease Prevalence
      • 7.3.2.4 Competitive Scenario
      • 7.3.2.5 Regulatory Framework
      • 7.3.2.6 Reimbursement Scenario
    • 7.3.3 Germany
      • 7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Key Country Dynamics
      • 7.3.3.3 Target Disease Prevalence
      • 7.3.3.4 Competitive Scenario
      • 7.3.3.5 Regulatory Framework
      • 7.3.3.6 Reimbursement Scenario
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Key Country Dynamics
      • 7.3.4.3 Target Disease Prevalence
      • 7.3.4.4 Competitive Scenario
      • 7.3.4.5 Regulatory Framework
      • 7.3.4.6 Reimbursement Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 Key Country Dynamics
      • 7.3.5.3 Target Disease Prevalence
      • 7.3.5.4 Competitive Scenario
      • 7.3.5.5 Regulatory Framework
      • 7.3.5.6 Reimbursement Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.6.2 Key Country Dynamics
      • 7.3.6.3 Target Disease Prevalence
      • 7.3.6.4 Competitive Scenario
      • 7.3.6.5 Regulatory Framework
      • 7.3.6.6 Reimbursement Scenario
    • 7.3.7 Sweden
      • 7.3.7.1 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.7.2 Key Country Dynamics
      • 7.3.7.3 Target Disease Prevalence
      • 7.3.7.4 Competitive Scenario
      • 7.3.7.5 Regulatory Framework
      • 7.3.7.6 Reimbursement Scenario
    • 7.3.8 Denmark
      • 7.3.8.1 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.8.2 Key Country Dynamics
      • 7.3.8.3 Target Disease Prevalence
      • 7.3.8.4 Competitive Scenario
      • 7.3.8.5 Regulatory Framework
      • 7.3.8.6 Reimbursement Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.9.2 Key Country Dynamics
      • 7.3.9.3 Target Disease Prevalence
      • 7.3.9.4 Competitive Scenario
      • 7.3.9.5 Regulatory Framework
      • 7.3.9.6 Reimbursement Scenario
    • 7.3.10 Rest Of Europe
      • 7.3.10.1 Rest Of Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific, SWOT Analysis
    • 7.4.2 India
      • 7.4.2.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.2.2 Key Country Dynamics
      • 7.4.2.3 Target Disease Prevalence
      • 7.4.2.4 Competitive Scenario
      • 7.4.2.5 Regulatory Framework
      • 7.4.2.6 Reimbursement Scenario
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.3.2 Key Country Dynamics
      • 7.4.3.3 Target Disease Prevalence
      • 7.4.3.4 Competitive Scenario
      • 7.4.3.5 Regulatory Framework
      • 7.4.3.6 Reimbursement Scenario
    • 7.4.4 Japan
      • 7.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.4.2 Key Country Dynamics
      • 7.4.4.3 Target Disease Prevalence
      • 7.4.4.4 Competitive Scenario
      • 7.4.4.5 Regulatory Framework
      • 7.4.4.6 Reimbursement Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.5.2 Key Country Dynamics
      • 7.4.5.3 Target Disease Prevalence
      • 7.4.5.4 Competitive Scenario
      • 7.4.5.5 Regulatory Framework
      • 7.4.5.6 Reimbursement Scenario
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.6.2 Key Country Dynamics
      • 7.4.6.3 Target Disease Prevalence
      • 7.4.6.4 Competitive Scenario
      • 7.4.6.5 Regulatory Framework
      • 7.4.6.6 Reimbursement Scenario
    • 7.4.7 THAILAND
      • 7.4.7.1 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.7.2 Key Country Dynamics
      • 7.4.7.3 Target Disease Prevalence
      • 7.4.7.4 Competitive Scenario
      • 7.4.7.5 Regulatory Framework
      • 7.4.7.6 Reimbursement Scenario
    • 7.4.8 Rest Of APAC
      • 7.4.8.1 Rest Of APAC Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America, SWOT Analysis
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.2.2 Key Country Dynamics
      • 7.5.2.3 Target Disease Prevalence
      • 7.5.2.4 Competitive Scenario
      • 7.5.2.5 Regulatory Framework
      • 7.5.2.6 Reimbursement Scenario
    • 7.5.3 Brazil
      • 7.5.3.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.3.2 Key Country Dynamics
      • 7.5.3.3 Target Disease Prevalence
      • 7.5.3.4 Competitive Scenario
      • 7.5.3.5 Regulatory Framework
      • 7.5.3.6 Reimbursement Scenario
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.4.2 Key Country Dynamics
      • 7.5.4.3 Target Disease Prevalence
      • 7.5.4.4 Competitive Scenario
      • 7.5.4.5 Regulatory Framework
      • 7.5.4.6 Reimbursement Scenario
    • 7.5.5 Rest Of LATAM
      • 7.5.5.1 Rest Of LATAM Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 Middle East & Africa, SWOT Analysis
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 Key Country Dynamics
      • 7.6.2.3 Target Disease Prevalence
      • 7.6.2.4 Competitive Scenario
      • 7.6.2.5 Regulatory Framework
      • 7.6.2.6 Reimbursement Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Key Country Dynamics
      • 7.6.3.3 Target Disease Prevalence
      • 7.6.3.4 Competitive Scenario
      • 7.6.3.5 Regulatory Framework
      • 7.6.3.6 Reimbursement Scenario
    • 7.6.4 UAE
      • 7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Key Country Dynamics
      • 7.6.4.3 Target Disease Prevalence
      • 7.6.4.4 Competitive Scenario
      • 7.6.4.5 Regulatory Framework
      • 7.6.4.6 Reimbursement Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 Key Country Dynamics
      • 7.6.5.3 Target Disease Prevalence
      • 7.6.5.4 Competitive Scenario
      • 7.6.5.5 Regulatory Framework
      • 7.6.5.6 Reimbursement Scenario
    • 7.6.6 Rest Of MEA
      • 7.6.6.1 Rest Of MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Public Companies
    • 8.1.1 Company Market Position Analysis
    • 8.1.2 Competitive Dashboard Analysis
    • 8.1.3 Strategic Framework
  • 8.2 Private Companies
    • 8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 8.2.2 Regional Network Map
  • 8.3 Company Profiles
    • 8.3.1 Varian Medical Systems, Inc. (A Part Of Siemens Healthineers)
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Elekta AB
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Accuray Incorporated
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Ion Beam Applications (IBA).
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 BD (Becton, Dickinson And Company)
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Isoray Medical
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 Mevion Medical Systems
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Product Benchmarking
      • 8.3.7.3 Strategic Initiatives
    • 8.3.8 Nordion Inc.
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Product Benchmarking
      • 8.3.8.3 Strategic Initiatives
    • 8.3.9 NTP Radioisotopes SOC Ltd.
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Curium
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Product Benchmarking
      • 8.3.10.3 Strategic Initiatives
    • 8.3.11 VIEWRAY TECHNOLOGIES, INC.
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Radiation Oncology Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 8 Global Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 U.K. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 U.K. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 U.K. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 France Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 France Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Italy Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Spain Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Spain Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Denmark Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Sweden Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Norway Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 46 Norway Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Japan Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 China Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 China Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 India Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 India Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Australia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Australia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Thailand Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Latin America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Brazil Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 Mexico Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Mexico Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Argentina Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 Argentina Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 South Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 90 South Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 South Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 UAE Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 UAE Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Radiation oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Radiation oncology market snapshot
  • Fig. 10 Radiation oncology market segmentation
  • Fig. 11 Radiation oncology market driver impact
  • Fig. 12 Radiation oncology market restraint impact
  • Fig. 13 Key market opportunities
  • Fig. 14 SWOT analysis, by factor (political & legal economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Radiation oncology market: Type outlook and key takeaways
  • Fig. 17 Radiation oncology market: Type movement analysis
  • Fig. 18 External beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Electron-emitting high energy linear accelerators market, 2018 - 2030 (USD Million)
  • Fig. 20 Compact advanced radiotherapy systems market, 2018 - 2030 (USD Million)
  • Fig. 21 CyberKnife market, 2018 - 2030 (USD Million)
  • Fig. 22 Gamma Knife market, 2018 - 2030 (USD Million)
  • Fig. 23 Tomotherapy market, 2018 - 2030 (USD Million)
  • Fig. 24 Proton therapy market, 2018 - 2030 (USD Million)
  • Fig. 25 Cyclotron market, 2018 - 2030 (USD Million)
  • Fig. 26 Synchrotron market, 2018 - 2030 (USD Million)
  • Fig. 27 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 28 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Seeds market, 2018 - 2030 (USD Million)
  • Fig. 30 Applicators and after-loaders market, 2018 - 2030 (USD Million)
  • Fig. 31 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 32 Systemic beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2016-2028 (USD Million)
  • Fig. 34 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology outlook and key takeaways
  • Fig. 35 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology movement analysis
  • Fig. 36 Radiation oncology market: Internal Beam Radiation Therapy (IBRT) technology movement analysis
  • Fig. 37 EBRT market, 2018 - 2030 (USD Million)
  • Fig. 38 IGRT market, 2018 - 2030 (USD Million)
  • Fig. 39 IMRT market, 2018 - 2030 (USD Million)
  • Fig. 40 Stereotactic radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 41 Proton beam therapy market, 2018 - 2030 (USD Million)
  • Fig. 42 3D-CRT market, 2018 - 2030 (USD Million)
  • Fig. 43 VMAT market, 2018 - 2030 (USD Million)
  • Fig. 44 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 45 LDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 HDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Radiation oncology market: Application outlook and key takeaways
  • Fig. 48 Radiation oncology market: EBRT Application movement analysis
  • Fig. 49 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 50 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 51 Lung cancer market, 2018 - 2030 (USD Million)
  • Fig. 52 Head and neck cancer market, 2018 - 2030 (USD Million)
  • Fig. 53 Colorectal cancer market, 2018 - 2030 (USD Million)
  • Fig. 54 Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 56 Gynecologic cancer market, 2018 - 2030 (USD Million)
  • Fig. 57 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 58 Cervical cancer market, 2018 - 2030 (USD Million)
  • Fig. 59 Penile cancer market, 2018 - 2030 (USD Million)
  • Fig. 60 Others market, 2018 - 2030 (USD Million)
  • Fig. 61 Radiation Oncology market: Regional outlook and key takeaways
  • Fig. 62 Radiation Oncology Market: Regional Movement Analysis
  • Fig. 63 North America
  • Fig. 64 North America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 65 U.S.
  • Fig. 66 U.S. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 67 Canada
  • Fig. 68 Canada radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 69 Europe
  • Fig. 70 Europe radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 71 Germany
  • Fig. 72 Germany radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 73 U.K.
  • Fig. 74 U.K. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 75 France
  • Fig. 76 France radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 77 Italy
  • Fig. 78 Italy radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 79 Spain
  • Fig. 80 Spain radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 81 Denmark
  • Fig. 82 Denmark radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Sweden
  • Fig. 84 Sweden radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Norway
  • Fig. 86 Norway radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Rest of Europe
  • Fig. 88 Rest of Europe radiation oncology Market, 2018 - 2030 (USD Million
  • Fig. 89 Asia Pacific
  • Fig. 90 Asia Pacific radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 91 Japan
  • Fig. 92 Japan radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 93 China
  • Fig. 94 China radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 95 India
  • Fig. 96 India radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 97 South Korea
  • Fig. 98 South Korea radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 99 Australia
  • Fig. 100 Australia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 101 Thailand
  • Fig. 102 Thailand radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 103 Rest of APAC
  • Fig. 104 Rest of APAC radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 105 Latin America
  • Fig. 106 Latin America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 107 Brazil
  • Fig. 108 Brazil radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 109 Mexico
  • Fig. 110 Mexico radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 111 Argentina
  • Fig. 112 Argentina radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 113 Rest of LATAM
  • Fig. 114 Rest of LATAM radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 115 Middle East & Africa
  • Fig. 116 Middle East and Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 117 South Africa
  • Fig. 118 South Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 119 Saudi Arabia
  • Fig. 120 Saudi Arabia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 121 UAE
  • Fig. 122 UAE radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 123 Kuwait
  • Fig. 124 Kuwait radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Rest of MEA
  • Fig. 126 Rest of MEA radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Company market share analysis
  • Fig. 128 Company market position analysis (Total revenue)
  • Fig. 129 Company market position analysis (Profit margin)
  • Fig. 130 Competitive dashboard analysis
  • Fig. 131 Regional Network Map
  • Fig. 132 Strategic Framework